Rapamycin is considered by many geroscience researchers to be the “gold standard” of anti-aging drugs; with lifespan improvement typically 15% to 30%, and as high as 37% when combined with another longevity drug “Acarbose”. While these results have been in animals, there are early indications that these benefits may also translate to people. BUT, rapamycin is a serious drug that can have serious…